fashion -WSS

fashion

author：knowledge 2025-08-26 10:54:45 - browse：768

NICOLAS MAETERLINCK/BELGA MAG/AFP via Getty Images

LONDON — Novavax, the beleaguered maker of a Covid-19 vaccine, just got a boost of its own.

The French pharma company Sanofi on Friday said it had reached a licensing deal to sell Novavax’s Covid shot going forward as well as to try to combine the vaccine with Sanofi’s own flu shot. The pact includes a $500 million upfront payment, with up to $700 million more on the table if certain regulatory and launch milestones are reached.

While Novavax’s stock soared during the pandemic as the vaccine race was underway, the company failed to get its shot authorized in the U.S. market until July 2022, long after the makers of mRNA vaccines had reaped billions in sales. Sales have sputtered along since then, and last year, the Maryland-based company warned that that it may not be able to stay in business.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Illumina to lay off 10% of research and development team

WSS

Lilly’s obesity pill cuts 15% of weight at highest dose in mid

GOP hopefuls to address prominent, controversial group questioning what's taught in schools

Prince Harry seeks over $550,000 in phone hacking lawsuit against British tabloid publisher

Tuskegee Airman Raymond Cassagnol dies at 102

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

STAT Summit: Ending the crisis of Black deaths in the U.S.

focus

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

explore

Novavax promises a turnaround & Lilly roils the obesity market

Federal board approves $12.7 billion budget for Puerto Rico as island shakes off bankruptcy

Sports medicine is finally prioritizing gender equality

ADA: All diabetes patients should be screened for liver condition

Peter Hotez and the public health issue of online harassment

Roivant's CEO is a star, but biotech's black hole persists

Alkermes shareholders re

UnitedHealth starts bidding war with $3.3 billion offer for Amedisys

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

STAT Readout: Friday, Oct. 20 biotech updates

focus

Thousands protest in Iraq for a second day over burning of Quran in Sweden

Lilly’s obesity pill cuts 15% of weight at highest dose in mid

Wildfire smoke map: Which US cities are forecast to be impacted by fires burning in Canada

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

Prince Harry seeks over $550,000 in phone hacking lawsuit against British tabloid publisher

Lilly’s obesity pill cuts 15% of weight at highest dose in mid

explore

focus

knowledge

hotspot